$285 Million is the total value of Atika Capital Management LLC's 152 reported holdings in Q2 2017. The portfolio turnover from Q1 2017 to Q2 2017 was 100.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| BMRN | Exit | BIOMARIN PHARMACEUTICAL INCcall | $0 | – | -5,100 | -100.0% | -0.22% | – |
| IPXL | Exit | IMPAX LABORATORIES INC | $0 | – | -39,500 | -100.0% | -0.24% | – |
| BPMC | Exit | BLUEPRINT MEDICINES CORP | $0 | – | -24,000 | -100.0% | -0.47% | – |
| RGLD | Exit | ROYAL GOLD INC | $0 | – | -19,000 | -100.0% | -0.65% | – |
| PCRX | Exit | PACIRA PHARMACEUTICALS INC | $0 | – | -31,000 | -100.0% | -0.69% | – |
| ARRY | Exit | ARRAY BIOPHARMA INC | $0 | – | -175,000 | -100.0% | -0.77% | – |
| ABBV | Exit | ABBVIE INCput | $0 | – | -30,000 | -100.0% | -0.96% | – |
| ACAD | Exit | ACADIA PHARMACEUTICALS INC | $0 | – | -65,200 | -100.0% | -1.10% | – |
| ALB | Exit | ALBEMARLE CORP | $0 | – | -22,000 | -100.0% | -1.14% | – |
| BMCH | Exit | BMC STK HLDGS INC | $0 | – | -107,000 | -100.0% | -1.18% | – |
| PTC | Exit | PTC INC | $0 | – | -48,000 | -100.0% | -1.24% | – |
| GDX | Exit | VANECK VECTORS ETF TRgold miners etf | $0 | – | -120,000 | -100.0% | -1.34% | – |
| ACXM | Exit | ACXIOM CORP | $0 | – | -98,700 | -100.0% | -1.38% | – |
| NXST | Exit | NEXSTAR MEDIA GROUP INCcl a | $0 | – | -41,500 | -100.0% | -1.43% | – |
| UAL | Exit | UNITED CONTL HLDGS INC | $0 | – | -41,400 | -100.0% | -1.43% | – |
| AGN | Exit | ALLERGAN PLC | $0 | – | -19,500 | -100.0% | -2.28% | – |
| INCY | Exit | INCYTE CORP | $0 | – | -36,000 | -100.0% | -2.36% | – |
| NVRO | Exit | NEVRO CORP | $0 | – | -67,200 | -100.0% | -3.08% | – |
| XBI | Exit | SPDR SERIES TRUSTput | $0 | – | -142,000 | -100.0% | -4.82% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2017-08-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| MARTIN MARIETTA MATLS INC | 38 | Q3 2023 | 6.1% |
| NETFLIX INC | 35 | Q2 2023 | 5.6% |
| MICROSOFT CORP | 32 | Q3 2023 | 6.7% |
| AMAZON COM INC | 29 | Q3 2023 | 8.6% |
| LIBERTY MEDIA CORP DELAWARE | 29 | Q2 2023 | 5.3% |
| META PLATFORMS INC | 25 | Q3 2023 | 5.8% |
| INTUITIVE SURGICAL INC | 24 | Q3 2023 | 3.3% |
| ARGENX SE | 23 | Q3 2023 | 1.6% |
| INSPIRE MED SYS INC | 22 | Q3 2023 | 5.1% |
| EPAM SYS INC | 22 | Q3 2022 | 1.8% |
View Atika Capital Management LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-14 |
| 13F-HR | 2024-02-13 |
| 13F-HR | 2023-11-13 |
| 13F-HR | 2023-08-11 |
| 13F-HR | 2023-05-12 |
| 13F-HR | 2023-02-13 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-12 |
| 13F-HR | 2022-05-13 |
| 13F-HR | 2022-02-11 |
View Atika Capital Management LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.